Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

$24.99

Income Statement

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Thermo Fisher Scientific Inc. for $24.99, or

  • get full access to the entire website for at least 3 months from $62.19.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Thermo Fisher Scientific Inc., consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Product revenues
Service revenues
Revenues
Cost of product revenues
Cost of service revenues
Cost of revenues
Gross profit
Selling, general and administrative expenses
Research and development expenses
Restructuring and other income (costs)
Operating income
Interest income
Interest expense
Other income (expense)
Income before income taxes
Provision for income taxes
Equity in losses of unconsolidated entities
Net income
Net (income) losses attributable to noncontrolling interests and redeemable noncontrolling interest
Net income attributable to Thermo Fisher Scientific Inc.

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Revenues Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Thermo Fisher Scientific Inc. revenues increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Operating income The net result for the period of deducting operating expenses from operating revenues. Thermo Fisher Scientific Inc. operating income decreased from 2021 to 2022 and from 2022 to 2023.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Thermo Fisher Scientific Inc. income before income taxes decreased from 2021 to 2022 and from 2022 to 2023.
Net income attributable to Thermo Fisher Scientific Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Thermo Fisher Scientific Inc. net income attributable to Thermo Fisher Scientific Inc. decreased from 2021 to 2022 and from 2022 to 2023.